SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is experiencing intense volatility as investors debate the impact of the upcoming SpaceX IPO, with many debating whether the stock's premium to its net asset value (NAV) is sustainable now that direct exposure to the underlying assets is becoming available. The community remains deeply divided, with some users accusing management of lack of transparency and harmful dilution while others view the current price action as an oversold buying opportunity ahead of anticipated catalysts involving other high-profile AI holdings like Anthropic and OpenAI.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are surging following a strong quarterly earnings report that featured a significant beat on both top and bottom lines, alongside an upward revision to full-year guidance. Community members are actively debating the stock's long-term growth potential and platform scale, while analysts have quickly responded by raising price targets across the board.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a historic, sentiment-driven rally fueled by intense demand for AI infrastructure, leaving bears trapped in a massive short squeeze while retail and institutional investors debate whether the momentum is justified by its rapid expansion. The stock has become a primary focal point for momentum traders who are actively comparing its parabolic trajectory to other historical tech bubbles while watching for signals of a potential split or a rapid reversal.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors weigh heavy valuation discounts and stagnant price performance against internal restructuring efforts and analyst discussions of deep value potential. Community sentiment remains divided, with some traders citing 'fintech obsolescence' and frustration over the stock's multi-year lows, while others continue to accumulate shares in anticipation of a long-term turnaround fueled by potential cost-cutting and AI integration.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as investors speculate on potential utility integrations and its long-term future alongside high-profile tech projects. The community remains deeply divided, balancing hopes for a major rally against frustrations over current price action and persistent market volatility.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is seeing a surge in investor interest driven by a combination of robust trading volumes, its expansion into event-based prediction markets, and active insider buying from company leadership. The community is focused on the platform's role in recent high-profile IPOs and its strategic pivot toward becoming a comprehensive financial super app.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense community debate over a high-stakes, evolving diplomatic memorandum between the U.S. and Iran, which many users are linking to significant market volatility. While some supporters celebrate the potential for a ceasefire and oil market stability, a vocal segment of the community is questioning the geopolitical trade-offs and criticizing the overall management of the conflict.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending as investors weigh its potential as a long-term turnaround play against the extreme volatility of regional conflicts in the Middle East. While the company is actively expanding its backlog and reducing debt ahead of its merger, the stock remains sensitive to fluctuating oil prices and uncertainty surrounding the closure of the Strait of Hormuz.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is facing intense volatility as the market reacts to the disappointing news that the Phase 2 AMPLIFY-7P study of its cancer vaccine did not meet its primary endpoint, leading to community concerns over the company's limited cash position and long-term viability. While some investors remain focused on potential niche clinical benefits and future development pathways, the prevailing sentiment in community discussions is one of frustration and skepticism regarding the stock's outlook.

Tidal Trust II - Defiance Daily 2X Space ETF

Defiance Daily 2X Space ETF

The Defiance Daily 2X Space ETF is currently facing significant uncertainty and investor frustration due to a regulatory trading halt that occurred shortly after its launch tied to the highly anticipated SpaceX IPO. The community is actively debating the duration of this halt, questioning potential reopening timelines, and expressing concerns over how the suspension impacts their leveraged exposure to the underlying stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the first patient has been dosed in the Phase 1, first-in-human trial of IM-1617, a potential first-in-class ADC directed at an undisclosed...

4 Biotech Stocks Investors Should Watch in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position LQDA, IMNM, STOK and IMCR well in this volatile sector. 

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the Company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on June 1, 2026, the Compensation Committee of the Companys Board of Directors (the Compensation Committee) granted inducement...

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in...

Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that members of Immunomes management will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, at 10:40 a.m...

What Offers Immunome (IMNM) a Compelling Investment Opportunity?

What Offers Immunome (IMNM) a Compelling Investment Opportunity...

Immunome Reports First Quarter 2026 Financial Results and Provides Business Update

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended March 31, 2026, and provided a business update. This quarter reflects the progress we are making in...

Techne (TECH) Misses Q3 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of -2.75% and -2.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Exelixis (EXEL) Tops Q1 Earnings Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of +15.55% and -0.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Immunome, Inc. (the Company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on May 1, 2026, the...

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

IMNMImmunome Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMNM News